SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-300303
Filing Date
2013-07-24
Accepted
2013-07-24 13:57:10
Documents
3
Period of Report
2013-07-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d572950d8k.htm 8-K 16359
2 EX-99.1 d572950dex991.htm EX-99.1 7320
3 GRAPHIC g572950logo.jpg GRAPHIC 16460
  Complete submission text file 0001193125-13-300303.txt   47704
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Filer) CIK: 0001327467 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54852 | Film No.: 13983356
SIC: 2834 Pharmaceutical Preparations